Pearson syndrome – Patient Worthy

source: pixabay.com

Minovia Kicks Off Phase I/II Trial of Experimental Pearson Syndrome Treatment

Post author:Scott Carlson
Post published:July 10, 2019
Post category:Mitochondrial Disease

According to a publication from Business Wire, the Israeli biotechnology company Minovia Therapeutics recently finished dosing the first participant in a phase I/II clinical study of the Company's experimental mitochondrial…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More